Mersana Therapeutics
Latest round
- Series C
Last raised
- Jun 2016
Total raised
- $92M
Investors
- 12
About Mersana Therapeutics
Mersana Therapeutics, Inc.Founded in 2001 and headquartered in Cambridge, US, Mersana Therapeutics focuses on creating ADCs for various cancer types.Mersana Therapeutics specializes in developing ADCs, utilizing proprietary platforms such as Dolasynthen and Immunosynthen to produce customized therapies targeting specific cancers. Their ADCs are currently in different phases of clinical development, catering to healthcare providers and research institutions in North America and Europe. from 180 Degree Capital, PureTech Ventures, F-Prime Capital, ProQuest Investments, RHO, New Enterprise Associates, Pfizer Venture Investments, and Rock Springs Capital for an upfront payment of USD 129 million and will receive additional payment of USD 156 million upon achieving milestones.
Who invested in Mersana Therapeutics
12 investors across 8 rounds
See all investors in Mersana Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jun 15, 2016
Amount
$33M
Investors
Series D
Feb 20, 2015
Amount
$10M
Investors
Series C
Apr 8, 2014
Amount
$9.5M
Investors
Series C
Sep 27, 2013
Amount
$5M
Investors
Series C
Jul 27, 2012
Amount
$13M
Investors
Series B
Aug 8, 2008
Amount
$10M
Investors
Series B
Nov 1, 2005
Amount
$11M
Investors
Series A
Feb 19, 2002
Amount
$0.8M
Investors
Questions about Mersana Therapeutics
Who invested in Mersana Therapeutics?
Mersana Therapeutics has 12 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mersana Therapeutics raised?
Mersana Therapeutics has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Mersana Therapeutics last raise money?
Mersana Therapeutics's most recent round on record is a Series C, in Jun 2016.
What does Mersana Therapeutics do?
Mersana Therapeutics is a biotechnology company.
Where is Mersana Therapeutics headquartered?
Mersana Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Mersana Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mersana Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Mersana Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.